Cargando…
Survival outcomes of marijuana users in p16 positive oropharynx cancer patients
BACKGROUND: Oropharynx squamous cell carcinoma (OPSCC) has become the predominant subsite for head and neck mucosal cancers (HNC) due to the rise of human papillomavirus (HPV) related disease. Previous studies have suggested an association between marijuana use and HPV-related OPSCC. Despite this, n...
Autores principales: | Zhang, Han, Xie, Michael, Levin, Marc, Archibald, Stuart D., Jackson, B. Stanley, Young, J. E. M., Gupta, Michael K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720071/ https://www.ncbi.nlm.nih.gov/pubmed/31477184 http://dx.doi.org/10.1186/s40463-019-0365-4 |
Ejemplares similares
-
Marijuana and head and neck cancer: an epidemiological review
por: Xie, Michael, et al.
Publicado: (2018) -
Interferon Inducible IFI16 Expression in p16 Positive Squamous Cell Carcinoma of the Oropharynx
por: Yamauchi, Moriyasu, et al.
Publicado: (2013) -
Predictive Value of HPV, p53, and p16 in the Post-Treatment Evolution of Malignant Tumors of the Oropharynx and Retromolar Trigone–Oropharynx Junction
por: Cobzeanu, Bogdan Mihail, et al.
Publicado: (2020) -
Post-treatment PET/CT for p16-positive oropharynx cancer treated with definitive proton therapy
por: Alexander, Gregory S., et al.
Publicado: (2023) -
Benefit of chemotherapy as part of treatment for HPV DNA-positive but p16-negative squamous cell carcinoma of the oropharynx
por: Junor, E, et al.
Publicado: (2012)